Stock Rich List
#3493 on the rich list of 14,644 insiders

Jason Aryeh

Director at Ligand Pharmaceuticals; Director at Orchestra BioMed Holdings; Director at Lifecore Biomedical. Based in Palm Beach Gardens, Florida.

$33.0M
in disclosed stock, −$1.4M (−3.95%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
3493rd of 14,644
Companies held
3
Largest holding
LGND, 96.1% of total
Latest SEC filing
Nov 10, 2026
Listed but not counted
$6.0M

What the $33.0M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Ligand Pharmaceuticals LGND
Common Stock
Directly105,476$286.94$30.3M91.8%Form 4, Nov 10, 2026
Ligand Pharmaceuticals LGND
Common Stock
Through Trust5,025$286.94$1.4M4.4%Form 4, Dec 8, 2025
Orchestra BioMed Holdings OBIO
Common Stock, par value $0.0001 per share
Directly118,118$7.00$827K2.5%Form 4, May 18, 2026
Lifecore Biomedical LFCR
Common Stock
Directly69,967$6.37$446K1.4%Form 4, Jun 4, 2026

Share counts are the amounts Jason Aryeh reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Jason Aryeh's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Ligand Pharmaceuticals LGND
Common Stock
Indirect
Held by a company or fund the insider manages
13,000$286.94$3.7M—Form 4, Jun 5, 2026
Ligand Pharmaceuticals LGND
Common Stock
Through JALAA Equities, LP
Held by a company or fund the insider manages
8,000$286.94$2.3M—Form 4, Nov 10, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 10, 2026SoldLGND500$319.99$160KView
Nov 10, 2026SoldLGND844$320.00$270KView
Nov 10, 2026SoldLGND646$320.00$207KView
Nov 10, 2026SoldLGND10$320.02$3KView
Nov 10, 2026SoldLGND500$320.10$160KView
Nov 10, 2026SoldLGND500$320.20$160KView
Nov 4, 2026SoldLGND282$319.99$90KView
Nov 2, 2026SoldLGND700$320.43$224KView
Oct 30, 2026SoldLGND50$317.74$16KView
Oct 30, 2026SoldLGND50$318.23$16KView
Oct 30, 2026SoldLGND52$320.24$17KView
Oct 30, 2026SoldLGND1,209$320.42$387KView
Oct 30, 2026SoldLGND50$320.49$16KView
Jun 11, 2026SoldLGND4,500$250.00$1.1MView
Jun 10, 2026SoldLGND500$250.00$125KView
May 18, 2026BoughtOBIO665$3.75$2KView
May 15, 2026BoughtOBIO8,971$3.90$35KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
3490Thomas C. Dolan
Director, Madison Square Garden Entertainment. New York, NY
$33.0M−$289K (−0.87%)
3491Paul Manning
Chairman, President & CEO, Sensient Technologies. Milwaukee, WI
$33.0M−$315K (−0.94%)
3492Evan Bayh
Director, Marathon Petroleum. Bethesda, MD
$33.0M−$573K (−1.71%)
3493Jason Aryeh
Director, Ligand Pharmaceuticals. Palm Beach Gardens, FL
$33.0M−$1.4M (−3.95%)
3494Jeffrey Westphal
Insider, Vertex. King Of Prussia, PA
$33.0M−$230K (−0.69%)
3495Kyle Cerminara
Director, BK Technologies. Charlotte, NC
$33.0M−$897K (−2.65%)
3496Davis O'Connor
EVP, General Counsel, Permian Resources. Denver, CO
$33.0M−$265K (−0.80%)

Other Ligand Pharmaceuticals insiders

All LGND insiders

Questions

How much stock does Jason Aryeh own?

Jason Aryeh holds $32,979,673 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 3493rd on the Stock Rich List.

Is this Jason Aryeh's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Jason Aryeh last buy or sell stock?

The most recent open-market trade on file is a sale of 500 LGND shares on Nov 10, 2026 at $319.99.